Trexquant Investment LP Makes New Investment in Doximity, Inc. (NASDAQ:DOCS)

Trexquant Investment LP purchased a new stake in shares of Doximity, Inc. (NASDAQ:DOCS) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 183,388 shares of the company’s stock, valued at approximately $9,791,000. Trexquant Investment LP owned 0.10% of Doximity as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. Shaker Investments LLC OH bought a new stake in Doximity during the 4th quarter valued at approximately $559,000. Principal Financial Group Inc. raised its position in shares of Doximity by 1.5% during the fourth quarter. Principal Financial Group Inc. now owns 293,974 shares of the company’s stock valued at $15,695,000 after buying an additional 4,282 shares during the last quarter. Newbridge Financial Services Group Inc. purchased a new position in shares of Doximity in the fourth quarter worth $362,000. Stratos Wealth Partners LTD. bought a new position in shares of Doximity during the fourth quarter worth $203,000. Finally, Barclays PLC grew its stake in Doximity by 60.5% during the third quarter. Barclays PLC now owns 53,401 shares of the company’s stock valued at $2,327,000 after acquiring an additional 20,125 shares in the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Doximity Stock Up 2.2 %

Shares of Doximity stock opened at $57.96 on Thursday. The stock’s fifty day moving average is $65.63 and its two-hundred day moving average is $54.84. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21. The company has a market capitalization of $10.82 billion, a PE ratio of 57.96, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34.

Insider Transactions at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares in the company, valued at $366,463.20. This trade represents a 75.87 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 37.40% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Stephens began coverage on shares of Doximity in a report on Friday, December 20th. They set an “equal weight” rating and a $55.00 price objective for the company. KeyCorp dropped their price target on Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a research note on Wednesday, January 8th. Piper Sandler raised Doximity from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $31.00 to $78.00 in a report on Friday, February 7th. Leerink Partners raised shares of Doximity from a “market perform” rating to an “outperform” rating and raised their target price for the company from $60.00 to $90.00 in a report on Friday, February 7th. Finally, The Goldman Sachs Group upped their price target on shares of Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Doximity currently has a consensus rating of “Moderate Buy” and an average target price of $64.22.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.